| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/19/2011 | CN101190277B Method for preparing stemmacantha uniflora blood circulation-activating, stasis-removing and wind-damp-expelling wine |
| 01/19/2011 | CN101156947B Ginseng source peptide albumen, its preparing method and application |
| 01/19/2011 | CN101112393B Surface-active substance composition moireuphe and method for preparing the same and use thereof |
| 01/19/2011 | CN101011419B Propolis preparation and its preparation method |
| 01/18/2011 | US7872112 comprising rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A),deoxyhypusine synthase (DHS) nucleic acids and polypeptides; human cytomegalovirus immediate-early promoter/enhancer |
| 01/18/2011 | US7871986 provides a prostate specific antigen oligo-epitope peptide (PSA-OP) that is useful as an immunogen in the prevention or treatment of prostatic cancer and in the inhibition of prostatic cancer cells and in the establishment and characterization of PSA-specific cytotoxic T-cell lines |
| 01/18/2011 | US7871765 Composition having antitumor effect |
| 01/18/2011 | US7871646 Preparing mammalian amniotic membrane extract; obtain healthy amniotic membrane from pregnant mammal, homogenize, centrifuge, quick freeze, lyophilize, store |
| 01/18/2011 | US7871631 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 01/18/2011 | US7871630 Locally administering to tumor antigen-releasing agent, tumor leukocyte attractant and tumor interferon-gamma (IFN-g), and second type 1 inflammatory response-(IR1-)promoting agent for tumor therapy |
| 01/18/2011 | US7871627 Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation |
| 01/18/2011 | US7871606 Use of stimulated peripheral-blood mononuclear cells for the treatment of cancerous diseases |
| 01/18/2011 | US7871604 microbial cells (avirulent Salmonella) comprising Environmentally Limited Viability System; cell is viable in permissive environment and non-viable or temporarily viable in non-permissive environment; antigen for expression of gamete-specific antigens to induce immune responses to block fertility |
| 01/18/2011 | CA2458797C Preparation and diabetic use of gibeberellins |
| 01/18/2011 | CA2426107C Methods and compositions for tissue regeneration |
| 01/18/2011 | CA2383737C Muc-1 derived peptides |
| 01/18/2011 | CA2380537C An oncolytic adenovirus |
| 01/18/2011 | CA2320807C Method and composition for treatment of inflammatory conditions |
| 01/13/2011 | WO2011005756A1 Delivery of agents targeted to microbiota niches |
| 01/13/2011 | WO2011005718A1 Apolipoprotein ciii in pre- and type 2 diabetes |
| 01/13/2011 | WO2011005717A1 Phenotypic ratio of serum amyloid in pre- and type 2 diabetes |
| 01/13/2011 | WO2011005381A2 Vortex-induced silk fibroin gelation for encapsulation and delivery |
| 01/13/2011 | WO2011005323A2 Process for removing growth factors from platelets |
| 01/13/2011 | WO2011005306A2 Production of and uses for decellularized lung tissue |
| 01/13/2011 | WO2011004911A1 Method of inducing differentiation from pluripotent stem cells to skeletal muscle progenitor cells |
| 01/13/2011 | WO2011004201A1 Preserved compositions of activated nk cells and methods of using the same |
| 01/13/2011 | WO2011004132A1 Novel hsp90-inhibiting indole derivatives, compositions containing said derivatives, and use thereof |
| 01/13/2011 | WO2011003995A1 Product for the storage of freeze-dried lactic acid bacteria mixed with a powder for an oral rehydration solution |
| 01/13/2011 | WO2011003988A1 A method for inducing extended self-renewal of functionally differentiated somatic cells |
| 01/13/2011 | WO2011003221A1 A medicine composition for treating bronchial asthma and preparative method thereof |
| 01/13/2011 | WO2011003194A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 01/13/2011 | WO2011003191A1 Compositions and methods for enhancing virus efficacy |
| 01/13/2011 | WO2010130851A3 Method for preparing at least one compound from blood, and sampling device for use when carrying out said method |
| 01/13/2011 | WO2010123200A3 Bacteriophage which kills pathogenic enteric bacteria |
| 01/13/2011 | WO2010105257A3 Generation of mouse induced pluripotent stem cells bytransient expression of a single non- viral polycistronic vector |
| 01/13/2011 | US20110009963 Biocompatible scaffold for ligament or tendon repair |
| 01/13/2011 | US20110008543 Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers |
| 01/13/2011 | US20110008459 Universally applicable blood plasma |
| 01/13/2011 | US20110008458 Process for removing growth factors from platelets |
| 01/13/2011 | US20110008457 Compositions and methods for modulating lipid composition |
| 01/13/2011 | US20110008449 Human Specific Escherichia Coli Strains |
| 01/13/2011 | US20110008443 Photocrosslinked biodegradable hydrogel |
| 01/13/2011 | US20110008417 Immunomodulating compositions and uses therefor |
| 01/13/2011 | US20110008406 Silk Fibroin Hydrogels and Uses Thereof |
| 01/13/2011 | US20110008397 Compartmental extract compositions for tissue engineering |
| 01/13/2011 | US20110008363 Erythropoietin variants |
| 01/13/2011 | US20110008361 Treatment Method |
| 01/13/2011 | US20110008353 Identification of astrovirus va1 associated with gastroenteritis in humans |
| 01/13/2011 | US20110008351 Anticomplement polypeptides of ixodes ricinus |
| 01/13/2011 | US20110008335 Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using NK Cell Potentiating Compounds |
| 01/13/2011 | US20110008310 Methods and compositions for mitochondrial replacement therapy |
| 01/13/2011 | US20110008304 Use of cells to facilitate targeted delivery of nanoparticle therapies |
| 01/13/2011 | US20110008303 Methods for treatment and prevention of mrsa/mssa |
| 01/13/2011 | US20110008302 Compositions and methods for immortalizing cells and screening for anti-cancer agents |
| 01/13/2011 | US20110008301 Human adipose derived insulin making mesenchymal stem cells for treating diabetes mellitus |
| 01/13/2011 | US20110008300 Cryopreservation of Adipose Tissue for the Isolation of Mesenchymal Stem Cells |
| 01/13/2011 | US20110008299 Treatment of pelvic floor disorders with an adipose-derived cell composition |
| 01/13/2011 | US20110008298 Method of deriving progenitor cell line |
| 01/13/2011 | US20110008297 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
| 01/13/2011 | US20110008296 Muscle-derived cells having differentiation capacities |
| 01/13/2011 | US20110008295 Simian adenoviruses sadv-36, -42.1, -42.2, and -44 and uses thereof |
| 01/13/2011 | US20110008294 Methods for treating cancer with mva |
| 01/13/2011 | US20110008293 Device and method for preparing microparticles |
| 01/13/2011 | US20110008292 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 01/13/2011 | US20110008291 Use of antifungal compositions to treat upper gastrointestinal conditions |
| 01/13/2011 | US20110008281 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia |
| 01/13/2011 | US20110008266 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| 01/13/2011 | CA2767825A1 Cardiac tissue-derived cells |
| 01/13/2011 | CA2767674A1 Process for removing growth factors from platelets |
| 01/13/2011 | CA2767600A1 Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions |
| 01/13/2011 | CA2767561A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 01/13/2011 | CA2767043A1 Inhibiting inflammation with milk oligosaccharides |
| 01/13/2011 | CA2765504A1 A method for inducing extended self-renewal of functionally differentiated somatic cells |
| 01/13/2011 | CA2765066A1 Compositions and methods for enhancing virus efficacy |
| 01/13/2011 | CA2760008A1 Product for the storage of freeze-dried lactic acid bacteria mixed with a powder for an oral rehydration solution |
| 01/12/2011 | EP2273268A2 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 01/12/2011 | EP2272859A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 01/12/2011 | EP2272526A2 Adjuvant for transcutaneous immunization |
| 01/12/2011 | EP2272523A1 Compounds, compositions, formulations and process for preparation thereof and method of treatment and management of acidity and related disorders |
| 01/12/2011 | EP2272522A2 Therapeutic compositions for use in prophylaxis or treatment of diarrheas |
| 01/12/2011 | EP2272513A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2272512A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2271748A2 Enhancing vessel lesion homing and repair potential of stem cells |
| 01/12/2011 | EP2271354A2 Reinforced tissue graft |
| 01/12/2011 | EP2271209A1 Materials and methods for hypothermic collection of whole blood |
| 01/12/2011 | EP2271208A1 Mehtod, system, and apparatus for hypothermic collection, storage, transport and banking of birth tissue |
| 01/12/2011 | EP1639509B1 Protein crystal comprising the processivity clamp factor of dna polymerase and a ligand, and its uses |
| 01/12/2011 | EP1272206B1 A chicken II GnRH analog for use in reducing tumor cell growth |
| 01/12/2011 | EP1254951B1 Molecule transferring device, auxiliary for molecule transferring device, and molecule transferring method |
| 01/12/2011 | EP0821736B1 Bacteriocins |
| 01/12/2011 | CN201701515U Artemisinine compound suppository for treatment of female genital disease |
| 01/12/2011 | CN201700858U Height adjustable healthcare pillow |
| 01/12/2011 | CN1977040B Compound WS 727713 |
| 01/12/2011 | CN1939431B Medicine for treating prostatic accrementition |
| 01/12/2011 | CN1785272B Medicinal composition and its preparation method |
| 01/12/2011 | CN1738595B Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 01/12/2011 | CN1353994B Method for creating human/goat hemopoietic stem cell heteroplastic transplantation model |
| 01/12/2011 | CN101945662A Nutraceutical composition and methods of use |
| 01/12/2011 | CN101945661A Nutraceutical composition and methods of use |
| 01/12/2011 | CN101945660A Anti-tumor effective paramyxovirus |